新型孕激素的药理作用及其临床应用

被引:2
作者
马丽 [1 ,2 ]
谢淑武 [1 ]
曹霖 [1 ]
朱焰 [1 ]
机构
[1] 上海市计划生育科学研究所
[2] 复旦大学
关键词
孕激素; 避孕; 新型孕激素; 体内代谢; 相关疾病;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100706 [药理学];
摘要
新一代孕激素经结构调整后只结合孕激素受体以发挥其孕激素活性,无明显其他激素作用,受体选择性更强,疗效更佳。其中代表性的新型孕激素包括:地诺孕素、屈螺酮、醋酸诺美孕酮、曲美孕酮和和醋酸烯诺孕酮。新孕激素的设计更接近天然孕酮的结构和功能,在用于避孕和激素替代治疗时,对体内代谢和相关疾病的也产生了影响,如静脉血栓栓塞、脂类代谢和动脉硬化、雄激素过多症及乳腺肿瘤等。总之,这类孕激素还需要进行更多的基础与临床研究,以找到高效低毒的新型孕激素。
引用
收藏
页码:78 / 81
页数:4
相关论文
共 11 条
[1]
Dienogest inhibits BrdU uptake with G 0 /G 1 arrest in cultured endometriotic stromal cells.[J].Li Fu;Yutaka Osuga;Chieko Morimoto;Tetsuya Hirata;Yasushi Hirota;Tetsu Yano;Yuji Taketani.Fertility and Sterility.2008, 5
[2]
Preclinical and clinical properties of trimegestone: A potent and selective progestin [J].
Sitruk-Ware, Regine ;
Bossemeyer, Ronald ;
Bouchard, Phillipe .
GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (06) :310-319
[3]
A one-year randomized double-blind; multicentre study to evaluate the effects of an oestrogen-reduced; continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women.[J].Jan Endrikat;Evelyn Lange;Michael Kunz;Werner Schmidt;Thomas Graeser.European J. of Contraception and Reproductive Healthcare.2007, 3
[4]
Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest [J].
Wiegratz, Inka ;
Mittmann, Katrin ;
Dietrich, Horst ;
Zimmermann, Thomas ;
Kuhl, Herbert .
FERTILITY AND STERILITY, 2006, 85 (06) :1812-1819
[5]
High-dose pilot study with the novel progestogen dienogest in patients with endometriosis [J].
Schindler, AE ;
Christensen, B ;
Henekel, A ;
Oettel, M ;
Moore, C .
GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (01) :9-17
[6]
Effects of a single Silastic? contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year.[J].Ione Cristina Barbosa;Hugo Maia;Elsimar Coutinho;Renata Lopes;Antonio C.V. Lopes;Cristina Noronha;Adelmo Botto.Contraception.2006, 6
[7]
Controversies about HRT - lessons from monkey models [J].
Clarkson, TB ;
Appt, SE .
MATURITAS, 2005, 51 (01) :64-74
[8]
Pharmacology of different progestogens: the special case of drospirenone.[J].R. Sitruk-Ware.Climacteric.2005, S3
[9]
Progestogen-only contraception in women at high risk of venous thromboembolism [J].
Conard, J ;
Plu-Bureau, G ;
Bahi, N ;
Horellou, MH ;
Pelissier, C ;
Thalabard, JC .
CONTRACEPTION, 2004, 70 (06) :437-441
[10]
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins [J].
Wiegratz, I ;
Kutschera, E ;
Lee, JH ;
Moore, C ;
Mellinger, U ;
Winkler, UH ;
Kuhl, H .
CONTRACEPTION, 2003, 67 (01) :25-32